Gemzar Injection 1 g/26.3 ml contains Gemcitabine. It is a widely used cytotoxic anticancer medicine administered under strict medical supervision in hospital or oncology settings.
Gemzar is commonly used either alone or in combination with other chemotherapy agents to treat a variety of solid tumors.
রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন
Composition
Each vial contains:
-
Gemcitabine 1 g in 26.3 ml solution
For intravenous (IV) infusion only.
Mechanism of Action
Gemcitabine works by:
-
Interfering with DNA synthesis in rapidly dividing cells
-
Incorporating into DNA strands and causing chain termination
-
Blocking cell replication during the S-phase of the cell cycle
-
Leading to cancer cell death
Because cancer cells divide more rapidly than normal cells, they are more susceptible to its effects.
Indications
Gemzar Injection is indicated for the treatment of:
-
Non-Small Cell Lung Cancer
-
Pancreatic Cancer
-
Bladder Cancer
-
Breast cancer (in combination therapy)
-
Ovarian cancer (as part of chemotherapy regimens)
Dosage and Administration
-
Administered intravenously by healthcare professionals only
-
Dose is based on body surface area, type of cancer, and treatment protocol
-
Given in cycles with rest periods between doses
-
Requires careful monitoring during administration
Benefits
Gemzar Injection offers:
-
Effective inhibition of cancer cell growth
-
Broad application across multiple cancer types
-
Can be used in combination chemotherapy regimens
-
Helps slow disease progression
-
Improves survival outcomes in certain cancers
Possible Side Effects
Common side effects include:
-
Nausea and vomiting
-
Fatigue
-
Fever
-
Loss of appetite
-
Hair thinning or loss
Less common side effects:
-
Low white blood cell count (leukopenia)
-
Low platelet count (thrombocytopenia)
-
Elevated liver enzymes
Serious side effects (require immediate attention):
-
Myelosuppression
-
Severe infections
-
Lung toxicity (interstitial pneumonitis)
-
Kidney or liver dysfunction
Precautions
-
Should be used only under oncologist supervision
-
Regular blood tests are required during treatment
-
Use cautiously in patients with liver, kidney, or bone marrow disorders
-
Avoid use during pregnancy and breastfeeding
-
Report fever, bleeding, or breathing difficulty immediately
Drug Interactions
Gemcitabine may interact with:
-
Other chemotherapy drugs
-
Radiation therapy (may increase toxicity)
-
Drugs affecting bone marrow function
Storage
-
Store at controlled room temperature as directed
-
Protect from light
-
Do not freeze
-
Use prepared solution only as instructed by healthcare professionals